You are here

Closed

Reset

NOTE: The Solicitations and topics listed on this site are copies from the various SBIR agency solicitations and are not necessarily the latest and most up-to-date. For this reason, you should visit the respective agency SBIR sites to read the official version of the solicitations and download the appropriate forms and rules.

Displaying 201 - 210 of 19116 results
  1. 1: Topic L: Plant HYperaccumulators TO MIne Nickel-Enriched Soils (PHYTOMINES)

    Release Date: 03-21-2024Open Date: 03-21-2024Due Date: 05-07-2024Close Date: 05-07-2024

    1 Exploratory Topics SBIR/STTR: Plant HYperaccumulators TO MIne Nickel-Enriched Soils (PHYTOMINES) ...

    SBIR/STTRPhase I/Phase IIDepartment of EnergyARPA-E
  2. A244-018: Tactical Implementation of Quantum Hardening

    Release Date: 10-03-2023Open Date: 03-05-2024Due Date: 03-31-2025Close Date: 04-23-2024

    OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Quantum Science; Advanced Computing and Software; Integrated Network System of Systems The technology within this topic is restricted under the International Traffic in Arms Regulation (ITAR), 22 CFR Parts 120 – 130, which controls the export and import of defense-related material and services, including export of sensitive technical data, or the Expor ...

    SBIRPhase I/Phase IIDepartment of DefenseArmy
  3. A244-015: Novel Positioning, Navigation, and Timing (PNT) Signal Classification Techniques

    Release Date: 10-03-2023Open Date: 03-04-2024Due Date: 03-31-2025Close Date: 04-22-2024

    OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Trusted Artificial Intelligence (AI) and Autonomy; Integrated Sensing and Cyber OBJECTIVE: The purpose of this topic is to develop the capability to classify signals in real-time that impact navigation systems. The intent is to better understand the type(s) of signal(s) experienced in relevant environments to appropriately apply mitigation techniques be ...

    SBIRPhase I/Phase IIDepartment of DefenseArmy
  4. A244-016: Autonomous Optical Sensors

    Release Date: 10-03-2023Open Date: 03-04-2024Due Date: 03-31-2025Close Date: 04-22-2024

    OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Integrated Sensing and Cyber; Trusted AI and Autonomy; Integrated Network Systems-of-Systems OBJECTIVE: This project aims to develop a portable optical sensor that can capture high-quality real-time imagery data during missile tests. The sensor will be positioned near a missile launcher during the launch or near the target to analyze the terminal phase of t ...

    SBIRPhase I/Phase IIDepartment of DefenseArmy
  5. A244-P006: xTechScalable AI

    Release Date: 10-03-2023Open Date: 01-03-2024Due Date: 03-31-2025Close Date: 04-17-2024

    OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Trusted AI and Autonomy; Advanced Computing and Software; Human-Machine Interfaces OBJECTIVE: xTechScalable AI is seeking novel, disruptive concepts and technology solutions that can assist in tackling the Army’s current needs and apply to current Army concepts. Current Machine Learning pipelines are vulnerable to manipulation of code, data, labels, and ...

    SBIRPhase I/Phase IIDepartment of DefenseArmy
  6. HR0011ST2024D-02: Reasoned Cyber Visualization (RC-Vis)

    Release Date: 10-03-2023Open Date: 02-26-2024Due Date: 03-31-2025Close Date: 04-15-2024

    OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Advanced Computing and Software The technology within this topic is restricted under the International Traffic in Arms Regulation (ITAR), 22 CFR Parts 120-130, which controls the export and import of defense-related material and services, including export of sensitive technical data, or the Export Administration Regulation (EAR), 15 CFR Parts 730-774, wh ...

    STTRPhase IDepartment of Defense
  7. RFA-AA-24-001: High-Throughput Screening (HTS) Platform for Discovery of Medications to Treat Alcohol Use Disorder (R43/R44 Clinical Trials Not Allowed)

    Release Date: 12-21-2023Open Date: 03-05-2024Due Date: 04-09-2024Close Date: 04-10-2024

    Drug development is challenging, particularly for Central Nervous System (CNS) medications. It takes approximately 18 years to move a potential CNS medication from its initial discovery phase to the marketplace, often costing several billion dollars. The failure rate is high (only 8% of new CNS compounds entering Phase I studies will reach the market) and contributes to the high costs and slow rat ...

    SBIRPhase I/Phase IIDepartment of Health and Human ServicesNational Institutes of Health
  8. RFA-AA-24-002: High-Throughput Screening (HTS) Platform for Discovery of Medications to Treat Alcohol Use Disorder (R41/R42 Clinical Trials Not Allowed)

    Release Date: 12-21-2023Open Date: 03-05-2024Due Date: 04-09-2024Close Date: 04-10-2024

    Drug development is challenging, particularly for Central Nervous System (CNS) medications. It takes approximately 18 years to move a potential CNS medication from its initial discovery phase to the marketplace, often costing several billion dollars. The failure rate is high (only 8% of new CNS compounds entering Phase I studies will reach the market) and contributes to the high costs and slow rat ...

    STTRPhase I/Phase IIDepartment of Health and Human ServicesNational Institutes of Health
  9. PAR-21-233: Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)

    Release Date: 04-23-2021Open Date: 07-10-2021 Due Dates: Multiple Close Date: 04-06-2024

    A. Overview Recent advances in biology offer unprecedented opportunities to discover new treatments for nervous system disorders. Biotherapeutic development, however, has inherent complexities with regards to characterization, manufacturing, delivery, and administration. Many academic laboratories and small business enterprises don’t have the full scope of expertise and resources available; thi ...

    SBIRPhase I/Phase IIDepartment of Health and Human ServicesNational Institutes of Health
  10. PAR-21-224: NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)

    Release Date: 05-05-2021Open Date: 08-05-2021 Due Dates: Multiple Close Date: 04-06-2024

    Purpose: To facilitate the cooperation and partnering of public and private funding organizations, universities, academic medical centers, research institutes, contract research organizations, biotechnology companies, and pharmaceutical companies, NINDS has formed the Neurology Network of Excellence in Clinical Trials (NeuroNEXT, www.NeuroNEXT.org). NeuroNEXT has a Clinical Coordinating Center (C ...

    SBIRPhase I/Phase IIDepartment of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government